As shown in Supplementary Figure 1C–1F, the survival model of BLCA patients with high expression of WDHD1 while enriching Th1 cells, B cells, CD4+ memory T cells or regulatory T cells can significantly reduce the survival of BLCA patients. This evidence concerns the gene WDHD1 and bladder transitional cell carcinoma.